A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers
Home News & Resources Publications A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers
A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers
Read entire article